Logan Hamilton: New Study Identifies the Mutated Antibody Gene Responsible for VITT
Logan Hamilton, Freelance Writer, shared a post on LinkedIn:
“Vaccine hesitancy often grows from misleading or conspiratorial claims.
Yet, rare vaccine side effects can still occur.
Previous research confirmed dangerous blood clots after some COVID-19 vaccinations. These clots appeared only after administration of adenovirus-based COVID-19 vaccines.
Scientists have now identified a likely cause of these symptoms, known as vaccine-induced thrombocytopenia and thrombosis (VITT). The team discovered a mutated antibody gene that causes VITT symptoms.
This gene was delivered by adenovirus COVID-19 vaccines. Results showed the mutation triggered rare but dangerous blood clotting.
VITT is extremely rare among vaccinated individuals. It occurred in about one in 200,000 recipients. Only adenovirus-based COVID-19 vaccines showed this risk. mRNA COVID-19 vaccines did not show the same pattern.”
Stay updated with Hemostasis Today.
-
Nov 17, 2026, 05:47Multidisciplinary Teams Kick Off SAHF MASAC ES 2026 with Pre-Symposium Workshops – South African Haemophilia Foundation
-
Nov 17, 2026, 05:41Boitumelo Malatji: South African Delegation Advances Advocacy Strategies at NNHF Southern Africa Workshop
-
Nov 17, 2026, 05:36Joining the PACTA Uganda Mental Health and Addiction Community Camp 2026 – Tackle Sickle Cell Africa
-
Nov 17, 2026, 05:30Nathan Connell: Women’s Hematology Summit 2027 to Address Hematologic Health Across the Lifespan
-
Nov 17, 2026, 05:25Mane Kurghinyan: Representing Armenia and HemAI Dynamics at the Falling Walls Lab Global Finale 2026
-
Nov 17, 2026, 01:27X. Long Zheng: Optimizing Treatment in Immune TTP
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH